Biosimilars Drug - Global and China Top Players Market Share and Ranking 2023

Report Code : AMP2757522
Published On: Oct, 2024
Category : Healthcare & Pharma
Pages : 169

According to Ample Market Research, the global market for Biosimilars Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Biosimilars Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Biosimilars Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report studies and analyses global Biosimilars Drug status and future trends, to help determine the Biosimilars Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Biosimilars Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Biosimilars Drug market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Biosimilars Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Biosimilars Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Biosimilars Drug key consuming regions, consumption value and demand structure
(5) Biosimilars Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Celltrion
Pfizer
Novartis
Dr Reddy’s
Celgen Biopharma
Eli Lilly
Sanofi
Geropharm
Biocon
Wockhardt
Market segment by Type, covers
Monoclonal Antibodies
Insulin
Others
Market segment by Application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Biosimilars Drug product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Biosimilars Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Biosimilars Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Biosimilars Drug industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
With tables and figures helping analyze worldwide Biosimilars Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

1 Market Overview
1.1 Biosimilars Drug Definition
1.2 Global Biosimilars Drug Market Size and Forecast
1.3 China Biosimilars Drug Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Biosimilars Drug Market Size: China VS Global Growth Rate, 2018-2029
1.6 Biosimilars Drug Market Dynamics
1.6.1 Biosimilars Drug Market Drivers
1.6.2 Biosimilars Drug Market Restraints
1.6.3 Biosimilars Drug Industry Trends
1.6.4 Biosimilars Drug Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Biosimilars Drug, Global Market Share by Company, 2018-2023
2.2 Global Biosimilars Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biosimilars Drug Concentration Ratio
2.4 Global Biosimilars Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Biosimilars Drug Major Companies Product Type
2.6 Head Office and Biosimilars Drug Production Site of Key Manufacturer

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Biosimilars Drug, China Market Share by Company, 2018-2023
3.2 China Biosimilars Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Biosimilars Drug Industry Chain
4.2 Biosimilars Drug Upstream Analysis
4.2.1 Biosimilars Drug Core Raw Materials
4.2.2 Main Manufacturers of Biosimilars Drug Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Biosimilars Drug Production Mode
4.6 Biosimilars Drug Procurement Model
4.7 Biosimilars Drug Industry Sales Model and Sales Channels
4.7.1 Biosimilars Drug Sales Model
4.7.2 Biosimilars Drug Typical Distributors

5 Sights by Type
5.1 Biosimilars Drug Classification
5.1.1 Monoclonal Antibodies
5.1.2 Insulin
5.1.3 Others
5.2 By Type, Global Biosimilars Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Biosimilars Drug Consumption Value, 2018-2029

6 Sights by Application
6.1 Biosimilars Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other
6.2 By Application, Global Biosimilars Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Biosimilars Drug Consumption Value, 2018-2029

7 Sales Sights by Region
7.1 By Region, Global Biosimilars Drug Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Biosimilars Drug Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Biosimilars Drug & Forecasts, 2018-2029
7.3.2 By Country, North America Biosimilars Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Biosimilars Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Biosimilars Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biosimilars Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Biosimilars Drug Market Size Market Share
7.6 South America
7.6.1 South America Biosimilars Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Biosimilars Drug Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Biosimilars Drug Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Biosimilars Drug Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Biosimilars Drug Market Size, 2018-2029
8.3.2 By Type, U.S. Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Biosimilars Drug Market Size, 2018-2029
8.4.2 By Type, Europe Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Biosimilars Drug Market Size, 2018-2029
8.5.2 By Type, China Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Biosimilars Drug Market Size, 2018-2029
8.6.2 By Type, Japan Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Biosimilars Drug Market Size, 2018-2029
8.7.2 By Type, South Korea Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Biosimilars Drug Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Biosimilars Drug Market Size, 2018-2029
8.9.2 By Type, India Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Biosimilars Drug Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Biosimilars Drug Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Biosimilars Drug Consumption Value Market Share, 2022 VS 2029

9 Company Profile
9.1 Qilu Pharmaceutical
9.1.1 Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.1.2 Qilu Pharmaceutical Company Profile and Main Business
9.1.3 Qilu Pharmaceutical Biosimilars Drug Models, Specifications and Application
9.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.1.5 Qilu Pharmaceutical Recent Developments
9.2 Bio-Thera
9.2.1 Bio-Thera Company Information, Head Office, Market Area and Industry Position
9.2.2 Bio-Thera Company Profile and Main Business
9.2.3 Bio-Thera Biosimilars Drug Models, Specifications and Application
9.2.4 Bio-Thera Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.2.5 Bio-Thera Recent Developments
9.3 Zhejiang Hisun
9.3.1 Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position
9.3.2 Zhejiang Hisun Company Profile and Main Business
9.3.3 Zhejiang Hisun Biosimilars Drug Models, Specifications and Application
9.3.4 Zhejiang Hisun Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.3.5 Zhejiang Hisun Recent Developments
9.4 Shanghai Henlius
9.4.1 Shanghai Henlius Company Information, Head Office, Market Area and Industry Position
9.4.2 Shanghai Henlius Company Profile and Main Business
9.4.3 Shanghai Henlius Biosimilars Drug Models, Specifications and Application
9.4.4 Shanghai Henlius Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.4.5 Shanghai Henlius Recent Developments
9.5 Innovent Biologics
9.5.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.5.2 Innovent Biologics Company Profile and Main Business
9.5.3 Innovent Biologics Biosimilars Drug Models, Specifications and Application
9.5.4 Innovent Biologics Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.5.5 Innovent Biologics Recent Developments
9.6 Jiangsu Hengrui
9.6.1 Jiangsu Hengrui Company Information, Head Office, Market Area and Industry Position
9.6.2 Jiangsu Hengrui Company Profile and Main Business
9.6.3 Jiangsu Hengrui Biosimilars Drug Models, Specifications and Application
9.6.4 Jiangsu Hengrui Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.6.5 Jiangsu Hengrui Recent Developments
9.7 Gan&Lee
9.7.1 Gan&Lee Company Information, Head Office, Market Area and Industry Position
9.7.2 Gan&Lee Company Profile and Main Business
9.7.3 Gan&Lee Biosimilars Drug Models, Specifications and Application
9.7.4 Gan&Lee Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.7.5 Gan&Lee Recent Developments
9.8 Tonghua Dongbao
9.8.1 Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position
9.8.2 Tonghua Dongbao Company Profile and Main Business
9.8.3 Tonghua Dongbao Biosimilars Drug Models, Specifications and Application
9.8.4 Tonghua Dongbao Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.8.5 Tonghua Dongbao Recent Developments
9.9 United Laboratory
9.9.1 United Laboratory Company Information, Head Office, Market Area and Industry Position
9.9.2 United Laboratory Company Profile and Main Business
9.9.3 United Laboratory Biosimilars Drug Models, Specifications and Application
9.9.4 United Laboratory Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.9.5 United Laboratory Recent Developments
9.10 3SBIO
9.10.1 3SBIO Company Information, Head Office, Market Area and Industry Position
9.10.2 3SBIO Company Profile and Main Business
9.10.3 3SBIO Biosimilars Drug Models, Specifications and Application
9.10.4 3SBIO Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.10.5 3SBIO Recent Developments
9.11 Luye Pharma
9.11.1 Luye Pharma Company Information, Head Office, Market Area and Industry Position
9.11.2 Luye Pharma Company Profile and Main Business
9.11.3 Luye Pharma Biosimilars Drug Models, Specifications and Application
9.11.4 Luye Pharma Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.11.5 Luye Pharma Recent Developments
9.12 Celltrion
9.12.1 Celltrion Company Information, Head Office, Market Area and Industry Position
9.12.2 Celltrion Company Profile and Main Business
9.12.3 Celltrion Biosimilars Drug Models, Specifications and Application
9.12.4 Celltrion Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.12.5 Celltrion Recent Developments
9.13 Pfizer
9.13.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.13.2 Pfizer Company Profile and Main Business
9.13.3 Pfizer Biosimilars Drug Models, Specifications and Application
9.13.4 Pfizer Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.13.5 Pfizer Recent Developments
9.14 Novartis
9.14.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.14.2 Novartis Company Profile and Main Business
9.14.3 Novartis Biosimilars Drug Models, Specifications and Application
9.14.4 Novartis Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.14.5 Novartis Recent Developments
9.15 Dr Reddy’s
9.15.1 Dr Reddy’s Company Information, Head Office, Market Area and Industry Position
9.15.2 Dr Reddy’s Company Profile and Main Business
9.15.3 Dr Reddy’s Biosimilars Drug Models, Specifications and Application
9.15.4 Dr Reddy’s Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.15.5 Dr Reddy’s Recent Developments
9.16 Celgen Biopharma
9.16.1 Celgen Biopharma Company Information, Head Office, Market Area and Industry Position
9.16.2 Celgen Biopharma Company Profile and Main Business
9.16.3 Celgen Biopharma Biosimilars Drug Models, Specifications and Application
9.16.4 Celgen Biopharma Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.16.5 Celgen Biopharma Recent Developments
9.17 Eli Lilly
9.17.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.17.2 Eli Lilly Company Profile and Main Business
9.17.3 Eli Lilly Biosimilars Drug Models, Specifications and Application
9.17.4 Eli Lilly Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.17.5 Eli Lilly Recent Developments
9.18 Sanofi
9.18.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.18.2 Sanofi Company Profile and Main Business
9.18.3 Sanofi Biosimilars Drug Models, Specifications and Application
9.18.4 Sanofi Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.18.5 Sanofi Recent Developments
9.19 Geropharm
9.19.1 Geropharm Company Information, Head Office, Market Area and Industry Position
9.19.2 Geropharm Company Profile and Main Business
9.19.3 Geropharm Biosimilars Drug Models, Specifications and Application
9.19.4 Geropharm Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.19.5 Geropharm Recent Developments
9.20 Biocon
9.20.1 Biocon Company Information, Head Office, Market Area and Industry Position
9.20.2 Biocon Company Profile and Main Business
9.20.3 Biocon Biosimilars Drug Models, Specifications and Application
9.20.4 Biocon Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.20.5 Biocon Recent Developments
9.21 Wockhardt
9.21.1 Wockhardt Company Information, Head Office, Market Area and Industry Position
9.21.2 Wockhardt Company Profile and Main Business
9.21.3 Wockhardt Biosimilars Drug Models, Specifications and Application
9.21.4 Wockhardt Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.21.5 Wockhardt Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
The Biosimilars Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

Is the Biosimilars Drug Global and China Top Players Market shifting its focus from growth to value?

Recognize the areas along the Biosimilars Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.

What are the major applications for Biosimilars Drug Global and China Top Players?

Biosimilars Drug Global and China Top Players has a wide range of applications, including and others.

What is the forecasted growth rate of the Biosimilars Drug Global and China Top Players Market?

The Biosimilars Drug Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.

What challenges does the Biosimilars Drug Global and China Top Players Market face in the future?

The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Biosimilars Drug Global and China Top Players Market across the extensive corporate landscape.

What makes the latest Biosimilars Drug Global and China Top Players Market study unique?

The latest version of the Biosimilars Drug Global and China Top Players Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.